Provided by Tiger Fintech (Singapore) Pte. Ltd.

Enanta Pharmaceuticals

6.56
-0.4200-6.02%
Post-market: 6.560.00000.00%18:05 EDT
Volume:189.48K
Turnover:1.26M
Market Cap:140.23M
PE:-1.45
High:7.04
Open:6.92
Low:6.50
Close:6.98
Loading ...
May 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 13, 2025

Major Issues Report

Form 8-K - Current report
Mar 18, 2025

Major Issues Report

Form 8-K - Current report
Feb 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 10, 2025

Major Issues Report

Form 8-K - Current report
Dec 09, 2024

Major Issues Report

Form 8-K - Current report
Nov 27, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 25, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Oct 17, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2024

Major Issues Report

Form 8-K - Current report
Jul 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 08, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2024

Major Issues Report

Form 8-K - Current report
Mar 12, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Correspondence

Form CORRESP - Correspondence